Authors:
Stark, H
Krause, M
Rouleau, A
Garbarg, M
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Enzyme-catalyzed prodrug approaches for the histamine H-3-receptor agonist(R)-alpha-methylhistamine, BIO MED CH, 9(1), 2001, pp. 191-198
Citation: M. Krause et al., Azomethine prodrugs of (R)-alpha-methylhistamine, a highly potent and selective histamine H-3-receptor agonist, CURR MED CH, 8(11), 2001, pp. 1329-1340
Authors:
Meier, G
Apelt, J
Reichert, U
Grassmann, S
Ligneau, X
Elz, S
Leurquin, F
Ganellin, CR
Schwartz, JC
Schunack, W
Stark, H
Citation: G. Meier et al., Influence of imidazole replacement in different structural classes of histamine H-3-receptor antagonists, EUR J PH SC, 13(3), 2001, pp. 249-259
Authors:
Schwartz, JC
Morisset, S
Rouleau, A
Tardivel-Lacombe, J
Gbahou, F
Ligneau, X
Heron, A
Sasse, A
Stark, H
Schunack, W
Ganellin, RC
Arrang, JM
Citation: Jc. Schwartz et al., Application of genomics to drug design: the example of the histamine H-3 receptor, EUR NEUROPS, 11(6), 2001, pp. 441-448
Authors:
Sasse, A
Ligneau, X
Sadek, B
Elz, S
Pertz, HH
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Stark, H
Citation: A. Sasse et al., Benzophenone derivatives and related compounds as potent histamine H-3-receptor antagonists and potential PET/SPECT ligands, ARCH PHARM, 334(2), 2001, pp. 45-52
Authors:
Reif, S
Kingreen, D
Kloft, C
Grimm, J
Siegert, W
Schunack, W
Jaehde, U
Citation: S. Reif et al., Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients, CANC CHEMOT, 48(2), 2001, pp. 134-140
Citation: A. Sasse et al., Separation of chiral 4-substituted imidazole derivatives by cyclodextrin-modified capillary electrophoresis, BIOMED CHRO, 15(1), 2001, pp. 25-30
Authors:
Warnke, U
Gysler, J
Hofte, B
Tjaden, UR
van der Greef, J
Kloft, C
Schunack, W
Jaehde, U
Citation: U. Warnke et al., Separation and identification of platinum adducts with DNA nucleotides by capillary zone electrophoresis and capillary zone electrophoresis coupled to mass spectrometry, ELECTROPHOR, 22(1), 2001, pp. 97-103
Authors:
Schlicker, E
Kozlowska, H
Kwolek, G
Malinowska, B
Kramer, K
Pertz, HH
Elz, S
Schunack, W
Citation: E. Schlicker et al., Novel histaprodifen analogues as potent histamine H-1-receptor agonists inthe pithed and in the anaesthetized rat, N-S ARCH PH, 364(1), 2001, pp. 14-20
Authors:
Nickel, T
Bauer, U
Schlicker, E
Kathmann, M
Gothert, M
Sasse, A
Stark, H
Schunack, W
Citation: T. Nickel et al., Novel histamine H-3-receptor antagonists and partial agonists with a non-aminergic structure, BR J PHARM, 132(8), 2001, pp. 1665-1672
Authors:
Bacciottini, L
Giovannelli, L
Passani, MB
Schunack, W
Mannaioni, PF
Blandina, P
Citation: L. Bacciottini et al., Ciproxifan and cimetidine modulate c-fos expression in septal neurons, andacetylcholine release from hippocampus of freely moving rats, INFLAMM RES, 49, 2000, pp. S41-S42
Authors:
Sasse, A
Stark, H
Ligneau, X
Elz, S
Reidemeister, S
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: A. Sasse et al., (Partial) agonist/antagonist properties of novel diarylalkyl carbamates onhistamine H-3 receptors, BIO MED CH, 8(5), 2000, pp. 1139-1149
Authors:
Stark, H
Ligneau, X
Sadek, B
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H-3-receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2379-2382
Authors:
Reif, S
Grimm, J
Kingreen, D
Siegert, W
Schunack, W
Jaehde, U
Citation: S. Reif et al., Pharmacokinetics of etoposide following administration of high-dose etoposide and etoposide phosphate, INT J CL PH, 38(3), 2000, pp. 156-157
Authors:
Bertaccini, G
Morini, G
Coruzzi, G
Schunack, W
Citation: G. Bertaccini et al., Histamine H-3 receptors in the guinea pig ileum: Evidence for a postjunctional location, J PHYSL-PAR, 94(1), 2000, pp. 1-4
Authors:
Malmberg-Aiello, P
Ipponi, A
Bartolini, A
Schunack, W
Citation: P. Malmberg-aiello et al., Antiamnesic effect of metoprine and of selective histamine H-1 receptor agonists in a modified mouse passive avoidance test, NEUROSCI L, 288(1), 2000, pp. 1-4
Citation: S. Elz et al., Ring-substituted histaprodifen analogues as partial agonists for histamineH-1 receptors: synthesis and structure-activity relationships, EUR J MED C, 35(1), 2000, pp. 41-52
Authors:
Miller, B
Altman, J
Leschke, C
Schunack, W
Sunkel, K
Knizek, J
Noth, H
Beck, W
Citation: B. Miller et al., Dinuclear palladium(II), platinum(II), and iridium(III) complexes of bis[imidazol-4-yl]alkanes, Z ANORG A C, 626(4), 2000, pp. 978-984
Authors:
Kiec-Kononowicz, K
Wiecek, M
Sasse, A
Ligneau, X
Elz, S
Ganellin, CR
Schwartz, JC
Stark, H
Schunack, W
Citation: K. Kiec-kononowicz et al., Importance of the lipophilic group in carbamates having histamine H-3-receptor antagonist activity, PHARMAZIE, 55(5), 2000, pp. 349-355
Authors:
Reidemeister, S
Stark, H
Ligneau, X
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: S. Reidemeister et al., Substituted N-phenylcarbamates as histamine H-3 receptor antagonists with improved in vivo potency, PHARMAZIE, 55(2), 2000, pp. 83-86